Search

Your search keyword '"Krajewski, W."' showing total 670 results

Search Constraints

Start Over You searched for: Author "Krajewski, W." Remove constraint Author: "Krajewski, W."
670 results on '"Krajewski, W."'

Search Results

1. Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery

2. The impact of venous thromboembolism on bladder cancer patients undergoing open or minimally-invasive radical cystectomy in the United States: Perioperative outcomes and health-care costs from insurance claims data

3. Is there a role for Bacillus Calmette-Güerin in very high-risk non-muscle invasive bladder carcinoma? Multicenter analysis of oncological outcomes and risk dynamics

4. Long-term oncological outcomes of de novo bladder cancer in kidney transplant recipients: results from a large multicenter international cohort

5. No impact of detrusor muscle absence in pTaHG urothelial bladder carcinoma first TURB

6. Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy

9. Oncologic outcomes of endoscopic management of upper tract urothelial carcinoma: A systematic review and pooled analysis from the EAU-YAU Urothelial Working Group

14. Role of thromboprophylaxis during neoadjuvant chemotherapy before radical cystectomy in patients with bladder cancer, results of a multicenter retrospective cohort study

15. Absence of Tumor (T0) on Second Transurethral Resection (ReTURB) Positively Impact Recurrence and Progression Risk Dynamics in a Contemporary Series of High-grade T1 Non-muscle Invasive Bladder Carcinoma Treated With Adequate Bacillus Calmette-Guérin

16. Enhancing Predictions of the EAU21 Scoring Model in High-Grade Non-Muscle Invasive Bladder Carcinoma Treated with BCG using Explainable Machine Learning Survival Ensemble

19. Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis

20. Die intravesikale Applikation von BCG induziert eine angeborene Immunreaktionen gegen SARS-CoV-2 beim Urothelkarzinom: Eine Premiere

21. Immune responses against SARS-CoV-2 wildtype in unvaccinated patients with high-risk NMIBC undergoing intravesical BCG therapy

22. Impact of pT-stage at second transurethral resection on recurrence and progression risk dynamics in a contemporary series of high-grade T1 bladder carcinoma treated with adequate bacillus Calmette-Guérin: Implications for management

23. Survival analysis of patients with T1LG bladder cancer treated with BCG immunotherapy

25. Absence de détrusor dans les tumeurs pTaHG : quel impact ?

26. Perioperative complications after radical cystectomy for bladder cancer: an international multicenter collaboration

27. A comparison between intracorporeal versus extracorporeal orthotopic ileal neobladder. Results from an european multi-institutional collaboration (YAU urothelial cancer group)

28. Evaluating the impact of complications on survival outcomes in patients treated with radical cystectomy for bladder cancer. Results from an european multi-institutional collaboration (YAU urothelial cancer group)

31. Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group

35. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology – Young Academic Urologists

36. Prediction of 90-day mortality after radical cystectomy for bladder cancer in large-scale multicenter collaboration study

37. The diagnostic issue of variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?

38. Oncological and safety profiles in patients undergoing simultaneous transurethral resection of bladder tumor and prostate: Results from a large multicenter international collaboration

39. Iowa Flood Center: Resource for Critical Research and Applications

41. P121 - Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in patients with pN+ bladder cancer

43. Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in patients with pN+ bladder cancer

45. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: a multicentre cohort from the european association of urology – young academic urologists (EAU-YAU): urothelial carcinoma working group

46. Ureteral stenting does not increase the risk of metachronous upper tract urothelial carcinoma in patients with bladder cancer presenting with hydronephrosis in comparison with percutaneous nephrostomy: a multicenter analysis

47. Radical nephroureterectomy pentafecta: a proposal for standardisation of oncologic outcomes reporting following open, laparoscopic or robot-assisted radical nephroureterectomy

48. Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: lessons learned from long-term follow-up of a series of CIS patients treated with BCG

49. Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in pN+ bladder cancer patients

50. Survival outcomes after radical cystectomy versus conservative management for T1 high grade non-muscle invasive micropapillary bladder cancer: a multicentre collaboration by the European Association of Urology – young academic urologists (EAU-YAU): urothelial carcinoma working group

Catalog

Books, media, physical & digital resources